2B4 stimulation of YT cells induces natural killer cell cytolytic function and invasiveness

Immunology

Volumn 100, Issue 3, 2000, Pages 378-383

  Chuang, S S ^a   Kim, M H ^a   Johnson, L A ^a   Albertsson, P ^b   Kitson, R P ^a   Nannmark, U ^b   Goldfarb, R H ^a   Mathew, P A ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GELATINASE A; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CELL STRAIN K 562; CYTOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MATRIX METALLOPROTEINASE 2; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033924467     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00031.x     Document Type: Article

References (35)

1. LANIER L.L. (1998) NK cell receptors. Annu Rev Immunol 16, 359.
2. SCOTT P. & TRINCHIERI G. (1995) The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 7, 34.
3. SPITS H., LANIER L.L. & PHILLIPS J.H. (1995) Development of human T and natural killer cells. Blood 85, 2654.
4. BIRON C.A. (1997) Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9, 24.
5. NAUME B. & ESPEVIK T. (1994) Immunoregulatory effects of cytokines on natural killer cells. J Immunol 40, 128.
6. LONG E.O., BURSHTYN D.N., CLARK W.P. et al. (1997) Killer cell inhibitory receptors: diversity, specificity, and function. Immunol Rev 155, 135.
7. MATHEW P.A., GARNI-WAGNER B.A., LAND K. et al. (1993) Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 151, 5328.
8. GARNI-WAGNER B.A., MATHEW P.A., BENNETT M. & KUMAR V. (1993) A novel function associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 151, 1117.
9. BOLES K.S., NAKAJIMA H., COLONNA M. et al. (1999) Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens 54, 27.
10. BROWN M.H., BOLES K.S., VAN DER MERWE P.A., KUMAR V., MATHEW P.A. & BARCLAY A.N. (1998) 2B4, the NK and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 188, 2083.
11. LATCHMAN Y., MCKAY P.F. & REISER H. (1998) Identification of the 2B4 molecule as a counter-receptor for CD48. J Immunol 161, 5809.
12. TANGYE S.G., LAZETIC S., WOOLLATT E., SUTHERLAND G.R., LANIER L.L. & PHILLIPS J.H. (1999) Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 162, 6981.
13. NAKAJIMA H., CELLA M., LANGEN H., FRIEDLEIN A. & COLONNA M. (1999) Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur J Immunol 29, 1676.
14. SAYOS J., WU C., MORRA M. et al. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462.
15. + T cells in HIV-1-infected patients with progressing disease. J Immunol 162, 7563.
16. KITSON R.P., APPASAMY P.M., NANNMARK U., ALBERTSSON P., GABAUER M.K. & GOLDFARB R.H. (1998) Matrix metalloproteinases produced by rat IL-2 activated natural killer cells. J Immunol 160, 4248.
17. ZENG L.S. & GOETZL E.J. (1996) Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Biochemistry 35, 7159.
18. WESTERMARCK J. & KAHARI V.M. (1999) Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13, 781.
19. HAGMANN W.K., LARK M.W. & BECKER J.W. (1996) Inhibition of matrix metalloproteinases. Annu Rep Med Chem 34, 231.
20. ENNIS B.W. & MATRISIAN L.M. (1994) Matrix degrading metalloproteinases. In: Brain Tumor Invasiveness (ed. R.H. Goldfarb), Kluwer, pp. 17-22. Dordrecht.
21. MATRISIAN L.M. (1992) The matrix-degrading metalloproteinases. Bio Essays 14, 455.
22. KAYAGAKI N., KAWASAKI A., EBATA T. et al. (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182, 1777.
23. Gearing A.J., Beckett P., Christodoulou M. et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555.
24. McGeehan G.M., Becherer J.D., Bast R.C. Jr et al. (1994) Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370, 558.
25. Yodoi J., Teshigawara K., Nikaido T. et al. (1985) TCGF (IL-2) - receptor inducing factor(s) I. Regulation of IL-2 receptor on a natural killer-like cell line (YT cells). J Immunol 134, 1623.
26. Collier I.E., Wilhelm S.M., Eisen A.Z. et al. (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263, 6579.
27. Will H. & Hinzmann B. (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231, 602.
28. Tso J.Y., Sun X.H., Kao T.H., Reece K.S. & Wu R. (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nuc Acids Res 12, 9179.
29. Bernard K., Cambiaggi A., Guia S. et al. (1999) Engagement of natural cytoxicity programs regulates AP-1 Expression in the NKL human NK cell line. J Immunol 162, 4062.
30. Valiante N.M. & Trinchieri G. (1993) Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 178, 1397.
31. Park C. & Schindler C. (1998) Protein-DNA interactions in interferon-γ signaling. Methods Enzymol 15, 175.
32. Kato K., Koyanagi M., Okada H. et al. (1992) CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 176, 1241.
33. Davis S.J. & Van der Merwe P.A. (1996) The structure and ligand interactions of CD2; implications for T cell function. Immunol Today 17, 177.
34. Qin H., Moellinger J.D., Wells A., Widsor L.J., Sun Y. & Benveniste E.N. (1998) Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-α and IFN-γ. J Immunol 161, 6664.
35. Cocks B.G., Chang C.C., Carbaiido J.M., Yssel H., De Vries J.E. & Aversa G. (1998) A novel receptor involved in T cell activation. Nature 376, 260.